1Y Target$14.26Near-term target
5Y Target$17.66Compound horizon
10Y Target$22.55Long-dated conviction
FCF$47mTTM · 03/26C-FCF $47m — barely positive; fragile cash position · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+7.1%TTM YoYBRevenue +7.1% — at or above S&P median · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E0.60totalBD/E 0.60 — at market average, manageable · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/E11.9xA-P/E 11.9 — cheap relative to market and most sectors
PEG1.68proxyC+PEG 1.68 — modest premium; above fair value · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Media · market cap $1.9b. Down 50% from 52-week high of $26.65 — deep drawdown territory.
Moat
Net margin 22% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 19% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Down 50% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Beta 2.32 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return.
Horizon
1-3 yr $14.26 (structural (no analyst coverage)) — multiple re-rating thesis requires a catalyst. 5 yr $17.66 at ~6% CAGR — dividend + buyback compounding. 10 yr $22.55 if the moat survives secular pressure.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.